Home/Filings/4/0000950170-25-038214
4//SEC Filing

Bruno Julianne 4

Accession 0000950170-25-038214

CIK 0001674416other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 7:05 PM ET

Size

14.6 KB

Accession

0000950170-25-038214

Insider Transaction Report

Form 4
Period: 2025-03-10
Bruno Julianne
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Shares

    2025-03-10+2,3999,461 total
  • Sale

    Common Shares

    2025-03-12$43.32/sh190$8,2318,508 total
  • Exercise/Conversion

    Common Shares

    2025-03-11+4358,698 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-102,3994,796 total
    Common Shares (2,399 underlying)
  • Sale

    Common Shares

    2025-03-11$42.42/sh1,198$50,8198,263 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-03-114350 total
    Common Shares (435 underlying)
Holdings
  • Common Shares

    (indirect: The Julianne Bruno 2022 GRAT)
    7,088
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
  • [F2]Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
  • [F3]This restricted stock unit award was granted on March 10, 2023 with respect to 9,593 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.
  • [F4]This restricted stock unit award was granted on March 11, 2021 with respect to 1,740 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025.

Documents

1 file

Issuer

CRISPR Therapeutics AG

CIK 0001674416

Entity typeother

Related Parties

1
  • filerCIK 0002019645

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 7:05 PM ET
Size
14.6 KB